Summary of the best evidence on non-pharmacological interventions for orthostatic hypotension in patients with Parkinson disease
10.3760/cma.j.cn115682-20230214-00491
- VernacularTitle:帕金森病患者直立性低血压非药物干预的最佳证据总结
- Author:
Meihong XIE
1
;
Wei KE
;
Huiqing MA
;
Fenhui WANG
;
Ying NI
;
Mingqing DU
;
Yifei SUN
;
Huixian ZHA
;
Hongyun YAN
Author Information
1. 南京医科大学附属苏州医院，苏州市立医院本部神经内科，苏州 215001
- Keywords:
Parkinson disease;
Orthostatic hypotension;
Non-pharmacological interventions;
Summary of evidence;
Evidence-based nursing
- From:
Chinese Journal of Modern Nursing
2023;29(23):3143-3149
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To search for and summarize the best evidence on non-pharmacological interventions for orthostatic hypotension in patients with Parkinson disease.Methods:Based on the 6S model, the relevant guidelines, clinical decisions, evidence summaries, systematic reviews and expert consensus on non-pharmacological interventions for orthostatic hypotension in Parkinson disease patients were systematically retrieved from domestic and foreign databases. The search time was from the establishment of the database to December 2022. Two researchers independently screened the literature, evaluated the quality of the included literature, and extracted and summarized evidence that met the quality standards.Results:A total of 15 articles were included, including 4 guidelines, 2 clinical decision-making articles, 1 evidence summary article, 3 systematic evaluations and 5 expert consensus articles. A total of 24 pieces of best evidence were summarized from 7 aspects, including purpose, evaluation, capacity intervention, exercise intervention, posture intervention, physical intervention, health education and support.Conclusions:The best evidence on non-pharmacological intervention for orthostatic hypotension in patients with Parkinson disease can provide a reference for the practice of clinical medical staffs. It is suggested to apply the best evidence in combination with the patient's condition, preference and clinical environment, so as to reduce the incidence of orthostatic hypotension in patients with Parkinson disease and to ensure the safety of patients.
